Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants

Anaerobe

Volumn 12, Issue 4, 2006, Pages 186-193

  Trejo, Fernando M ^a   Minnaard, Jessica ^a,b   Perez, Pablo F ^a,b   De Antoni, Graciela L ^a,b  

^a CENTRO DE INVESTIGACIÓN Y DESARROLLO EN CRIOTECNOLOGÍA DE ALIMENTOS CIDCA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Adhesion; Bifidobacterium; Clostridium difficile; Inhibition; Organic acids

Indexed keywords

CHYMOTRYPSIN; PROTEINASE K;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; HUMAN; INFANT; INTESTINE CELL; NORMAL HUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANTIBIOSIS; BACTERIAL ADHESION; BIFIDOBACTERIUM; CACO-2 CELLS; CLOSTRIDIUM DIFFICILE; ENTEROCYTES; HUMANS; INFANT; INFANT, NEWBORN;

BIFIDOBACTERIUM; CLOSTRIDIA; CLOSTRIDIUM DIFFICILE;

EID: 33748302984     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2006.03.004     Document Type: Article

References (41)

1. Bartlett J.G. Antibiotic-associated diarrhea. Clin Infect Dis 15 (1992) 573-581
2. Kamthan A.G., Bruckner H.W., Hirschman S.Z., and Agus S.G. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med 152 (1992) 1715-1717
3. McFarland L.V., and Stamm W.E. Review of Clostridium difficile-associated diseases. Am J Infect Control 14 (1986) 99-109
4. Bartlett J.G., Moon N., Chang T.W., Taylor N., and Onderdonk A.B. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75 5 (1978) 778-782
5. George R.H., Symonds J.M., Dimock F., Brown J.D., Arabi Y., Shinagawa N., et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1 6114 (1978) 695
6. Barbut F., and Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7 8 (2001) 405-410
7. Hurley B.W., and Nguyen C.C. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 162 (2002) 2177-2184
8. von Eichel-Streiber C., Boquet P., Sauerborn M., and Thelestam M. Large clostridial cytotoxins a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol. 4 10 (1996) 375-382
9. Calabi E., Calabi F., Phillips A.D., and Fairweather N.F. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Inf Immun 70 (2002) 5770-5778
10. Waligora A., Hennekin C., Mullany P., Bourlioux P., Collignon A., and Karjalainen T. Characterisation of a cell surface protein of Clostridium difficile with adhesive properties. Inf Immun 69 (2001) 2144-2153
11. Stark P.L., Lee A., and Parsonage B.D. Colonisation of the large bowel by Clostridium difficile in healthy infants: quantitative study. Inf Immun (1982) 895-899
12. Eglow R., Pothoulakis C., Itzkowitz S., Israel E.J., O'Keane C.J., Gong D., Gao N., Xu Y.L., et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. Clin Invest 90 3 (1992) 822-829
13. Dudley M.N., McLaughlin J.C., Carrington G., Frick J., Nightingale C.H., and Quintiliani R. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. Arch Intern Med 146 6 (1986) 1101-1104
14. Wenisch C., Parschalk B., Hasenhundl M., Hirschl A.M., and Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 23 2 (1996) 423
15. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob 16 (2000) 521-526
16. Cremonini F., Di Caro S., Santarelli L., Gabrielli M., Candelli M., Nista E.C., et al. Probiotics in antibiotic-associated diarrhoea. Dig Liver Dis 34 (2002) S78-S80
17. Ishibashi N., and Shimamura S. Bifidobacteria: research and development in Japan. Food Technol 47 (1993) 126-135
18. Fuller R. History and development of probiotics. In Fuller R, editor. Probiotics: the scientific basis. London: Chapman & Hall; 1992.
19. Gomez Zavaglia A., Kociubinski G., Pérez P.F., and De Antoni G.L. Isolation and characterization of Bifidobacterium strains for probiotic formulation. J Food Prot 61 7 (1998) 865-873
20. Perez P.F., Minnaard J., Disalvo E.A., and De Antoni G.L. Surface properties of bifidobacterial strains of human origin. Appl Environ Microbiol 64 (1998) 21-26
21. Kociubinski G.L., Pérez P.F., and De Antoni G.L. Screening of bile resistance and bile precipitation in lactic acid bacteria and Bifidobacteria. J Food Prot 62 8 (1999) 905-912
22. Bibiloni R., Pérez P.F., and De Antoni G.L. Will a high adhering capacity in a probiotic strain guarantee exclusion of pathogens from intestinal epithelia?. Anaerobe 5 (1999) 519-524
23. Be′langer S.D., Boissinot M., Clairoux N., Picard F.J., and Bergeron M.G. Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol 41 (2003) 730-734
24. Tasteyre A., Karjalainen T., Avesani V., Delme M., Cillignon A., Bourlioux P., and Barc M- C. Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol 38 (2000) 3179-3186
25. Kociubinski G L., Pérez P.F., Añon M.C., and De Antoni G.L. A method of screening for highly inhibitory lactic acid bacteria. J Food Prot 59 (1996) 739-745
26. Garrote G.L., Abraham A.G., and De Antoni G.L. Chemical and microbiological characterization of kefir grains. J Dairy Res 64 (2001) 639-652
27. Meynell GG, Meynell R, editors Bacterial growth. Counts of stained films. In: Theory and practice in experimental bacteriology. 2nd ed. Cambridge: University Press; 1970.
28. Brazier J.S. The epidemiology and typing of Clostridium difficile. Antimicrob Chemother 41 Suppl C (1998) 47-57
29. Matsuki S., Ozaki E., Shozu M., Inoue M., Shimizqu S., Yamaguchi N., et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 8 1 (2005) 43-48
30. Delmee M., Verellen G., Avesani V., and Francois G. Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 147 1 (1988) 36-40
31. el-Mohandes A.E., Keiser J.F., Refat M., and Jackson B.J. Prevalence and toxigenicity of Clostridium difficile isolates in fecal microflora of preterm infants in the intensive care nursery. Biol Neonate 63 4 (1993) 225-229
32. Kotowska M., Albrecht P., and Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21 5 (2005) 583-590
33. Plummer S., Weaver M.A., Harris J.C., Dee P., and Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 7 1 (2004) 59-62
34. Wullt M., Hagslatt M.L., and Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 35 6-7 (2003) 365-367
35. Lewis S., Burmeister S., and Brazier. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomizes, controlled study. Clin Gastroenterol Hepatol 3 5 (2005) 442-448
36. Colombel J.F., Cortot A., Neut, and Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 2 8549 (1987) 43
37. Bibiloni R., Pérez P.F., and De Antoni G.L. Factors involved in adhesion of bifidobacterial strains to epithelial cells in culture. Anaerobe 5 (1999) 483-485
38. Waligora A., Barc M- C., Bourlioux P., Collignon A., and Karjalainen T. Clostridium difficile cell attachment is modified by environmental factors. Appl Environ Microbiol 65 9 (1999) 4234-4238
39. Eveillard M., Fourel V., Barc M- C., Kernéis S., Coconier M- H., Karjalainen T., Bourlioux P., and Servin A.L. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture. Mol Microbiol 7 (1993) 371-381
40. Cerquetti M., Serafino A., Sebastianelli A., and Mastrantonio P. Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins. FEMS Immunol. Med Microbiol 32 (2002) 211-218
41. Chantret I., Rodolosse A., Barbat A., Dussaulx E., Brot-Laroche E., Zweibaum A., and Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence of glucose-dependent negative regulation. J Cell Sci 107 (1994) 213-225